| 产品详情 |
| Edit |   |
|---|
| Product Name | DMXAA |
|---|
| Description | MW: 282.29. Purity ≥98% by HPLC. Background: DMXAA acts as a tumor vascular disrupting agent, inducing apoptosis in tumor vascular endothelium resulting in necrosis at the tumor core. It potently activates the TANK-binding kinase 1-interferon regulatory factor 3 signaling pathway in leukocytes, inducing type-I-interferon production. In addition, DMXAA significantly inhibits several kinases in endothelial cells, including the vascular endothelial growth factor (VEGF) receptors VEGFR1 and VEGFR |
|---|
| Size | 5 mg, 25 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | [2-(5,6-dimethyl-9-oxoxanthen-4-yl)acetic acid; Vadimezan; ASA404] |
|---|
| Gene, Accession, CAS # | CAS: 117570-53-3 |
|---|
| Catalog # | MBS843151 |
|---|
| Price | |
|---|
| Order / More Info | DMXAA from MYBIOSOURCE INC. |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|